• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种检测长春新碱和长春花碱的灵敏放射免疫分析法。

A sensitive radioimmunoassay for vincristine and vinblastine.

作者信息

Sethi V S, Burton S S, Jackson D V

出版信息

Cancer Chemother Pharmacol. 1980;4(3):183-7. doi: 10.1007/BF00254016.

DOI:10.1007/BF00254016
PMID:7397941
Abstract

A rapid, sensitive and highly reproducible radioimmunoassay (RIA) has been devised for vincristine and vinblastine. These alkaloids bind to the antiserum very tightly with an association constant (Ka) of 5 x 10(9) M-1 as determined by Scatchard analysis. The kinetic association constant of the alkaloids, as determined by the 'on' and 'off' rates at 4 degrees C, is 30-fold higher than the Scatchard analysis value. At 4 degrees C, 80% of the alkaloid is bound to the antiserum within 20 min, and the remaining 20% reaches an equilibrium within 48-72 h. In the RIA procedure the amount of the alkaloid (1-2 ng) needed to compete for 50% binding remains unchanged when the reaction mixtures are incubated for 2, 4, or 20 h. By a modification of the RIA procedure, where the antiserum is first allowed to react with the unlabeled alkaloid followed by addition of the radiolabeled alkaloid, sensitivity of the assay has been increased five- to tenfold. Other drugs, such as adriamycin, CCNU, methyl CCNU, cyclophosphamide, 5-fluorouracil, heparin, hydrocortisone, prednisone, and nitrogen mustard do not interfere with the assay. This assay can thus be used to determine vincristine or vinblastine levels in 5 x 10(-10)--10(-9) M concentrations in biological fluids.

摘要

已设计出一种用于长春新碱和长春碱的快速、灵敏且高度可重复的放射免疫分析(RIA)方法。通过Scatchard分析确定,这些生物碱与抗血清紧密结合,结合常数(Ka)为5×10⁹ M⁻¹。通过4℃下的“结合”和“解离”速率测定,生物碱的动力学结合常数比Scatchard分析值高30倍。在4℃时,80%的生物碱在20分钟内与抗血清结合,其余20%在48 - 72小时内达到平衡。在RIA程序中,当反应混合物孵育2小时、4小时或20小时时,竞争50%结合所需的生物碱量(1 - 2 ng)保持不变。通过对RIA程序进行改进,即先让抗血清与未标记的生物碱反应,然后加入放射性标记的生物碱,该分析的灵敏度提高了五到十倍。其他药物,如阿霉素、洛莫司汀、甲基洛莫司汀、环磷酰胺、5 - 氟尿嘧啶、肝素、氢化可的松、泼尼松和氮芥不干扰该分析。因此,该分析可用于测定生物流体中浓度为5×10⁻¹⁰ - 10⁻⁹ M的长春新碱或长春碱水平。

相似文献

1
A sensitive radioimmunoassay for vincristine and vinblastine.一种检测长春新碱和长春花碱的灵敏放射免疫分析法。
Cancer Chemother Pharmacol. 1980;4(3):183-7. doi: 10.1007/BF00254016.
2
Radioimmunoassay of vinblastine and vincristine.长春碱和长春新碱的放射免疫测定
Br J Clin Pharmacol. 1977 Apr;4(2):169-72. doi: 10.1111/j.1365-2125.1977.tb00690.x.
3
Pharmacokinetics of vindesine and vincristine in humans.长春地辛和长春新碱在人体内的药代动力学。
Cancer Res. 1977 Aug;37(8 Pt 1):2603-7.
4
The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
Med Pediatr Oncol. 1982;10(2):115-27. doi: 10.1002/mpo.2950100202.
5
Human pharmacokinetics of a new Vinca alkaloid S 12363 with use of a monoclonal antibody-based radio- or enzyme immunoassay.
Cancer Res. 1993 Aug 1;53(15):3536-40.
6
Determination of vinca alkaloids in human plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.液相色谱/大气压化学电离质谱法测定人血浆中的长春花生物碱
Cancer Chemother Pharmacol. 1997;39(4):286-90. doi: 10.1007/s002800050574.
7
Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys.长春新碱、长春碱和长春地辛在恒河猴体内的药代动力学
Cancer Chemother Pharmacol. 1984;12(1):31-5. doi: 10.1007/BF00255905.
8
Solid-phase extraction of vinblastine and vincristine from plasma and urine: variable drug recoveries due to non-reproducible column packings.从血浆和尿液中固相萃取长春碱和长春新碱:由于柱填料不可重现导致药物回收率可变。
J Chromatogr. 1987 Feb 20;414(1):91-100. doi: 10.1016/0378-4347(87)80027-0.
9
Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).5'-去甲脱水长春碱(诺维本)在大鼠体内的放射免疫分析及初步药代动力学研究。
Cancer Res. 1984 Dec;44(12 Pt 1):5609-13.
10
Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.长春花生物碱与微管蛋白的相互作用:长春碱、长春新碱和长春瑞滨的比较。
Biochemistry. 1996 May 28;35(21):6806-14. doi: 10.1021/bi953037i.

引用本文的文献

1
Progress in Immunoassays of Toxic Alkaloids in Plant-Derived Medicines: A Review.植物源药物中有毒生物碱免疫分析方法的研究进展:综述
Toxins (Basel). 2022 Feb 23;14(3):165. doi: 10.3390/toxins14030165.
2
Pharmacokinetics of vincristine sulfate in children.硫酸长春新碱在儿童体内的药代动力学
Cancer Chemother Pharmacol. 1981;6(2):111-5. doi: 10.1007/BF00262326.
3
The protein binding of vinblastine in the serum of normal subjects and patients with Hodgkin's disease.长春碱在正常受试者和霍奇金病患者血清中的蛋白结合情况。

本文引用的文献

1
Pharmacological studies with vinblastine in the dog.长春碱在犬类中的药理学研究。
Cancer Res. 1975 May;35(5):1116-20.
2
The pharmacokinetics of 4-acetyl tritium vinblastine in two patients.两名患者体内4-乙酰基氚化长春碱的药代动力学。
Cancer Res. 1975 Apr;35(4):975-80.
3
Distribution and excretion of (3H)vincristine in the rat and the dog.(3H)长春新碱在大鼠和犬体内的分布与排泄
Eur J Clin Pharmacol. 1983;24(5):683-7. doi: 10.1007/BF00542223.
4
Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model.在犬类模型中使用皮下植入泵持续静脉输注长春花生物碱。
Cancer Chemother Pharmacol. 1983;10(3):217-20. doi: 10.1007/BF00255767.
5
Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine.长春碱连续5天输注的药代动力学与毒性
Cancer Chemother Pharmacol. 1984;12(1):43-5. doi: 10.1007/BF00255908.
6
Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys.长春新碱、长春碱和长春地辛在恒河猴体内的药代动力学
Cancer Chemother Pharmacol. 1984;12(1):31-5. doi: 10.1007/BF00255905.
7
Hepatic intra-arterial infusion of vincristine.肝动脉内注射长春新碱。
Cancer Chemother Pharmacol. 1984;13(2):120-2. doi: 10.1007/BF00257127.
8
Pharmacokinetics of vindesine bolus and infusion.
Cancer Chemother Pharmacol. 1984;13(2):114-9. doi: 10.1007/BF00257126.
9
Phase II trial of vincristine infusion in acute leukemia.长春新碱输注治疗急性白血病的II期试验。
Cancer Chemother Pharmacol. 1985;14(1):26-9. doi: 10.1007/BF00552720.
10
Clinical pharmacology of vinzolidine.长春利定的临床药理学
Cancer Chemother Pharmacol. 1986;16(1):70-4. doi: 10.1007/BF00255290.
Cancer Res. 1976 Oct;36(10):3684-9.
4
The pharmacokinetics of [3H]-vincristine in man.[3H] -长春新碱在人体中的药代动力学。
Clin Pharmacol Ther. 1977 Oct;22(4):430-5. doi: 10.1002/cpt1977224430.
5
Pharmacokinetics and metabolism of vinblastine in humans.
Cancer Res. 1977 Aug;37(8 Pt 1):2597-602.
6
Pharmacokinetics of vindesine and vincristine in humans.长春地辛和长春新碱在人体内的药代动力学。
Cancer Res. 1977 Aug;37(8 Pt 1):2603-7.
7
The distribution of [3H]vinblastine in tumor and host tissues of Nb rats bearting a transplantable lymphoma which is highly sensitive to the alkaloid.携带对该生物碱高度敏感的可移植性淋巴瘤的Nb大鼠的肿瘤和宿主组织中[3H]长春碱的分布。
Cancer Res. 1977 May;37(5):1455-60.
8
Biliary excretion of vincristine.长春新碱的胆汁排泄
Clin Pharmacol Ther. 1978 Jul;24(1):101-7. doi: 10.1002/cpt1978241101.
9
Radioimmunoassay of vinblastine and vincristine.长春碱和长春新碱的放射免疫测定
Br J Clin Pharmacol. 1977 Apr;4(2):169-72. doi: 10.1111/j.1365-2125.1977.tb00690.x.
10
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
J Med Chem. 1978 Jan;21(1):88-96. doi: 10.1021/jm00199a016.